Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M LeWinter

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
Circulation|September 15, 2010
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood InstituteThomas Force, Robert O Bonow, Steven R Houser, et al.
The New England Journal of Medicine|November 10, 2015
Isosorbide Mononitrate in Heart Failure with Preserved Ejection FractionMargaret M Redfield, Kevin J Anstrom, James A Levine, et al.
JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
The New England Journal of Medicine|November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndromeBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JAMA|March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialMargaret M Redfield, Horng H Chen, Barry A Borlaug, et al.
JAMA|November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trialHorng H Chen, Kevin J Anstrom, Michael M Givertz, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Circulation|September 15, 2010
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood InstituteThomas Force, Robert O Bonow, Steven R Houser, et al.
The New England Journal of Medicine|November 10, 2015
Isosorbide Mononitrate in Heart Failure with Preserved Ejection FractionMargaret M Redfield, Kevin J Anstrom, James A Levine, et al.
JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
The New England Journal of Medicine|November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndromeBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JAMA|March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialMargaret M Redfield, Horng H Chen, Barry A Borlaug, et al.
JAMA|November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trialHorng H Chen, Kevin J Anstrom, Michael M Givertz, et al.
Pageof 23